Low expression or inactivated mutation of Keap1 occurs in human non-small-cell lung carcinoma tissues including adenocarcinoma, leading to the increased expression and activation of Nrf2 [26,27]. Here, NFE2L2 is linked to non-small cell lung carcinoma.